HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kai-Wen Hsu Selected Research

Lysine (L-Lysine)

11/2023Interplay between lncRNA RP11-367G18.1 variant 2 and YY1 plays a vital role in hypoxia-mediated gene expression and tumorigenesis.
1/2023RP11-367G18.1 V2 enhances clear cell renal cell carcinoma progression via induction of epithelial-mesenchymal transition.
1/2022Nafamostat mesylate overcomes endocrine resistance of breast cancer through epigenetic regulation of CDK4 and CDK6 expression.
1/2021Induction of epithelial-mesenchymal transition (EMT) by hypoxia-induced lncRNA RP11-367G18.1 through regulating the histone 4 lysine 16 acetylation (H4K16Ac) mark.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kai-Wen Hsu Research Topics

Disease

24Neoplasms (Cancer)
11/2023 - 06/2009
13Neoplasm Metastasis (Metastasis)
12/2022 - 01/2016
7Hypoxia (Hypoxemia)
11/2023 - 01/2020
7Carcinogenesis
11/2023 - 08/2008
7Stomach Neoplasms (Stomach Cancer)
04/2020 - 06/2009
6Breast Neoplasms (Breast Cancer)
01/2022 - 01/2016
3Leukemia
04/2024 - 01/2020
3BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
04/2024 - 05/2019
3Thyroid Neoplasms (Thyroid Cancer)
01/2022 - 01/2019
3Triple Negative Breast Neoplasms
01/2021 - 01/2017
3Adenocarcinoma
12/2012 - 06/2009
2Adenocarcinoma of Lung
01/2022 - 09/2021
1Myeloid Leukemia (Leukemia, Myelocytic)
04/2024
1Disseminated Intravascular Coagulation
01/2022
1Lung Neoplasms (Lung Cancer)
01/2022
1Pancreatitis
01/2022
1Head and Neck Neoplasms (Head and Neck Cancer)
01/2021
1Uterine Cervical Neoplasms (Cancer of the Cervix)
12/2020
1Pancreatic Neoplasms (Pancreatic Cancer)
10/2020
1Philadelphia Chromosome
05/2020
1Blast Crisis (Blast Phase)
05/2019
1Chronic Disease (Chronic Diseases)
05/2019
1Anaplastic Thyroid Carcinoma
01/2018
1Acute Erythroblastic Leukemia (Erythroleukemia)
08/2012

Drug/Important Bio-Agent (IBA)

6Long Noncoding RNAIBA
11/2023 - 01/2020
6MicroRNAs (MicroRNA)IBA
01/2022 - 01/2014
5Histones (Histone)IBA
11/2023 - 02/2018
5Notch1 ReceptorIBA
06/2016 - 08/2008
4Lysine (L-Lysine)FDA Link
11/2023 - 01/2021
4RNA (Ribonucleic Acid)IBA
11/2023 - 01/2021
4Proteins (Proteins, Gene)FDA Link
05/2022 - 07/2014
4Estrogen ReceptorsIBA
01/2022 - 02/2018
3ChromatinIBA
12/2022 - 01/2021
2Biomarkers (Surrogate Marker)IBA
04/2024 - 01/2017
2Imatinib Mesylate (Gleevec)FDA Link
04/2024 - 05/2019
2LuteolinIBA
01/2021 - 01/2020
2Progesterone Receptors (Progesterone Receptor)IBA
01/2021 - 02/2018
2human ERBB2 proteinIBA
01/2021 - 02/2018
2PanobinostatIBA
01/2019 - 02/2018
2Transcription Factors (Transcription Factor)IBA
07/2014 - 08/2012
2Phosphopyruvate Hydratase (Enolase)IBA
01/2014 - 08/2008
2Cyclooxygenase 2 (Cyclooxygenase-2)IBA
12/2012 - 06/2009
2LigandsIBA
08/2012 - 06/2009
1Tyrosine Kinase InhibitorsIBA
04/2024
1AgarIBA
11/2023
1Histone Acetyltransferases (Histone Acetyltransferase)IBA
01/2023
1A-Form DNA (A-DNA)IBA
12/2022
1Exonucleases (3' 5' Exonuclease)IBA
12/2022
1MethyltransferasesIBA
12/2022
1Proliferating Cell Nuclear Antigen (PCNA)IBA
05/2022
1Tyrosine (L-Tyrosine)FDA Link
05/2022
1nafamostatIBA
01/2022
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2022
1Sunitinib (Sutent)FDA Link
01/2022
1AntagomirsIBA
01/2022
1Therapeutic UsesIBA
09/2021
1Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA
09/2021
1Androgen Receptors (Androgen Receptor)IBA
01/2021
1NucleosidesIBA
10/2020
1MucinsIBA
10/2020
1Interleukin-17 ReceptorsIBA
10/2020
1A 7 (A-7)IBA
10/2020
1GemcitabineFDA Link
10/2020
1Oncogene Proteins (Oncogene Protein)IBA
05/2020
1Mevalonic Acid (Mevalonate)IBA
04/2020
1EnzymesIBA
04/2020
13-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA)IBA
04/2020
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
04/2020
1Dipyridamole (Persantine)FDA LinkGeneric
04/2020
1TamoxifenFDA LinkGeneric
01/2020
1Mitochondrial DNA (mtDNA)IBA
01/2020
1Hormones (Hormone)IBA
01/2020
1MTOR InhibitorsIBA
01/2020
1bcr-abl Fusion ProteinsIBA
05/2019
1Histone Deacetylase InhibitorsIBA
01/2019
1Doxorubicin (Adriamycin)FDA LinkGeneric
02/2018
1belinostatIBA
02/2018
1ErbB Receptors (EGF Receptor)IBA
01/2018
1AfatinibIBA
01/2018
1LuciferasesIBA
06/2017
1Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA
01/2017
1Focal Adhesion Protein-Tyrosine KinasesIBA
06/2016
1Messenger RNA (mRNA)IBA
06/2016
13' Untranslated Regions (3' UTR)IBA
01/2016
1Basic Helix-Loop-Helix Transcription FactorsIBA
01/2016
1Cadherins (E-Cadherin)IBA
01/2016
1Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA
12/2012
1Notch ReceptorsIBA
12/2012
1Prostaglandins EIBA
12/2012
1Notch2 ReceptorIBA
12/2012
1N- (2- cyclohexyloxy- 4- nitrophenyl)methanesulfonamideIBA
12/2012
1STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA
08/2012
1Carrier Proteins (Binding Protein)IBA
12/2009

Therapy/Procedure

7Therapeutics
01/2022 - 08/2012
3Drug Therapy (Chemotherapy)
01/2021 - 01/2020
1Transplantation
06/2017